BIOA B — BioArctic AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK27.00bn
- SEK25.16bn
- SEK257.35m
- 55
- 13
- 99
- 58
Annual cashflow statement for BioArctic AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -85 | -140 | -17.4 | 253 | -229 |
| Depreciation | |||||
| Non-Cash Items | -20 | 5.23 | -55.4 | 2.46 | -68.1 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 12.7 | -5.96 | 27 | 47.2 | -30.4 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -92.3 | -140 | -31.6 | 310 | -316 |
| Capital Expenditures | -12.5 | -4.39 | -12.7 | -7.44 | -26.6 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.051 | -0.026 | -0.017 | -500 | 232 |
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -12.5 | -4.41 | -12.8 | -507 | 206 |
| Financing Cash Flow Items | — | — | — | -0.001 | -0.001 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -6.6 | -7.39 | -2.81 | 14.1 | 5.69 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -113 | -152 | -43 | -194 | -98.6 |